We are live on !
Find out more
AlphaCentric Advisors Portfolio holdings
AUM
$113M
Turnover
27.4%
1-Year Est. Return
27.37%
This Fund
S&P 500
This Quarter Est. Return
-3.08%
1 Year Est. Return
+27.37%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$113M
AUM Growth
-$5.41M
(-4.6%)
Cap. Flow
+$2.01M
Cap. Flow % of AUM
Cap. Flow %
1.79%
Top 10 Holdings %
Top 10 Hldgs %
23.44%
Holding
292
New
33
Increased
148
Reduced
40
Closed
47
Avg Time Held
1.2
years
Top 10 Avg Time Held
0.4
years
Top 20 Avg Time Held
0.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$4.34M |
| 2 |
Invesco S&P 500 Pure Value ETF
RPV
|
+$1.59M |
| 3 |
iShares Russell 1000 Value ETF
IWD
|
+$1.58M |
| 4 |
Alpine Income Property Trust
PINE
|
+$1.46M |
| 5 |
iShares US Real Estate ETF
IYR
|
+$1.03M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apogee Therapeutics
APGE
|
+$1.53M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.37M |
| 3 |
Invesco NASDAQ 100 ETF
QQQM
|
+$1.37M |
| 4 |
Howard Hughes
HHH
|
+$1.07M |
| 5 |
SmartStop Self Storage REIT
SMA
|
+$812K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 44.1% |
| 2 | Miscellaneous | 19.55% |
| 3 | Technology | 9.14% |
| 4 | Industrials | 8.04% |
| 5 | Real Estate | 7.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
Rhythm Pharmaceuticals
RYTM
$7.78B
| $935K | 0.83% |
9,821
+372
| +4% | +$39.7K |
2025 Q4
3 quarters
|
|
27
Biogen
BIIB
$36.7B
| $924K | 0.82% |
4,092
+201
| +5% | +$42.6K |
2025 Q4
3 quarters
|
|
28
Personalis
PSNL
$1.71B
| $909K | 0.81% |
55,854
-23,070
| -29% | -$348K |
2025 Q4
3 quarters
|
|
29
Saul Centers
BFS
$705M
| $902K | 0.8% |
30,000
-5,000
| -14% | -$169K |
2024 Q4
7 quarters
|
|
30
Pennant Park Investment Corp
PNNT
$218M
| $891K | 0.79% |
270,000
+20,000
| +8% | +$70.4K |
2026 Q1
2 quarters
|
|
31
Rockwell Automation
ROK
$41.7B
| $871K | 0.77% |
2,000
| – | – |
2024 Q3
8 quarters
|
|
32
Tempus AI
TEM
$13.9B
| $819K | 0.73% |
10,000
-5,000
| -33% | -$302K |
2026 Q1
2 quarters
|
|
33
Centerspace
CSR
$963M
| $816K | 0.72% |
15,000
+10,000
| +200% | +$553K |
2026 Q2
1 quarter
|
|
34
JPMorgan BetaBuilders Japan ETF
BBJP
$17.8B
| $781K | 0.69% |
9,943
+852
| +9% | +$65.4K |
2023 Q1
14 quarters
|
|
35
Xometry
XMTR
$6.63B
| $771K | 0.69% |
7,500
-2,500
| -25% | -$231K |
2026 Q1
2 quarters
|
|
36
ASML
ASML
$549B
| $770K | 0.68% |
+425
| New | +$737K |
2026 Q3
0 quarters
|
|
37
Globus Medical
GMED
$9.5B
| $749K | 0.67% |
10,000
| – | – |
2024 Q4
7 quarters
|
|
38
Stereotaxis
STXS
$109M
| $738K | 0.66% |
600,000
| – | – |
2020 Q2
25 quarters
|
|
39
Symbotic
SYM
$4.78B
| $736K | 0.65% |
17,500
+2,500
| +17% | +$105K |
2023 Q2
13 quarters
|
|
40
AeroVironment
AVAV
$5.73B
| $734K | 0.65% |
5,162
+1,511
| +41% | +$238K |
2024 Q1
10 quarters
|
|
41
iShares MSCI Australia ETF
EWA
$1.24B
| $725K | 0.64% |
25,625
+2,149
| +9% | +$62.8K |
2023 Q4
11 quarters
|
|
42
Ionis Pharmaceuticals
IONS
$6.55B
| $722K | 0.64% |
16,163
+733
| +5% | +$41.7K |
2024 Q4
7 quarters
|
|
43
Intuitive Surgical
ISRG
$160B
| $712K | 0.63% |
1,750
| – | – |
2020 Q2
25 quarters
|
|
44
Manhattan Associates
MANH
$14.7B
| $695K | 0.62% |
3,500
-1,500
| -30% | -$287K |
2026 Q1
2 quarters
|
|
45
Krystal Biotech
KRYS
$8.92B
| $680K | 0.6% |
2,046
+101
| +5% | +$35K |
2024 Q4
7 quarters
|
|
46
Redwire
RDW
$1.8B
| $679K | 0.6% |
65,000
| – | – |
2026 Q1
2 quarters
|
|
47
Edgewise Therapeutics
EWTX
$4.93B
| $673K | 0.6% |
16,572
+732
| +5% | +$31.1K |
2024 Q4
7 quarters
|
|
48
Ondas Inc
ONDS
$3.1B
| $660K | 0.59% |
90,000
| – | – |
2026 Q1
2 quarters
|
|
49
Synopsys
SNPS
$86.3B
| $652K | 0.58% |
1,500
| – | – |
2023 Q1
14 quarters
|
|
50
BioNTech
BNTX
$21.7B
| $644K | 0.57% |
6,547
+281
| +4% | +$27.3K |
2024 Q4
7 quarters
|
|
Similar funds
TWS
AlphaCentric Advisors's Q3 2026 Portfolio in Review
As of Q3 2026, AlphaCentric Advisors held 292 positions worth $113M, down 4.6% from $118M the previous quarter. Its ten largest holdings account for 23% of the portfolio.
AlphaCentric Advisors's Q3 2026 filing shows 33 new, 148 increased, 40 reduced and 47 closed positions. Its largest new stake was Alpine Income Property Trust: 75,000 shares worth $1.3M. The largest sale was Apogee Therapeutics, an estimated $1.53M.
By sector, the portfolio is most concentrated in Healthcare at 44% of assets, up from 44% a quarter earlier, followed by Miscellaneous and Technology.
- AlphaCentric Advisors's largest Q3 2026 buy was Alpine Income Property Trust: 75,000 shares worth $1.3M.
- AlphaCentric Advisors added most to iShares 1-3 Year Treasury Bond ETF in Q3 2026, an estimated $4.34M increase.
- AlphaCentric Advisors's biggest Q3 2026 reduction was Graphic Packaging, cutting an estimated $428K.
- AlphaCentric Advisors fully exited Apogee Therapeutics in Q3 2026, selling an estimated $1.53M.
- AlphaCentric Advisors's ten largest holdings make up 23% of its $113M portfolio in Q3 2026.
- AlphaCentric Advisors opened 33 new positions and closed 47 in Q3 2026.
- AlphaCentric Advisors's portfolio value fell 4.6% quarter-over-quarter to $113M.
Based on AlphaCentric Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.